XML 114 R39.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segments (Tables)
 12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Operations and Assets for Operating Segments and Geographic Information
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 
For the years ended December 31,
(In thousands)
2019
 
2018
 
2017
Revenue from services:
 
 
 
 
 
Pharmaceutical
$
—

 
$
—

 
$
—

Diagnostics
716,434

 
813,248

 
782,710

Corporate
—

 
—

 


 
$
716,434

 
$
813,248

 
$
782,710

Revenue from products:
 
 
 
 
 
Pharmaceutical
$
112,184

 
$
107,112

 
$
107,759

Diagnostics
—

 
—

 


Corporate
—

 
—

 


 
$
112,184

 
$
107,112

 
$
107,759

Revenue from transfer of intellectual property and other:
 
 
 
 
 
Pharmaceutical
$
73,317

 
$
69,906

 
$
75,537

Diagnostics
—

 
—

 


Corporate
—

 
—

 


 
$
73,317

 
$
69,906

 
$
75,537

Operating loss:
 
 
 
 
 
Pharmaceutical
$
(109,062
)
 
$
(82,641
)
 
$
(84,287
)
Diagnostics
(123,359
)
 
(44,942
)
 
(136,540
)
Corporate
(41,631
)
 
(43,614
)
 
(55,615
)
 
$
(274,052
)
 
$
(171,197
)
 
$
(276,442
)
Depreciation and amortization:
 
 
 
 
 
Pharmaceutical
$
30,073

 
$
28,007

 
$
27,513

Diagnostics
63,675

 
69,246

 
74,442

Corporate
59

 
91

 
138

 
$
93,807

 
$
97,344

 
$
102,093

Loss from investment in investees:
 
 
 
 
 
Pharmaceutical
$
(2,900
)
 
$
(10,822
)
 
$
(12,646
)
Diagnostics
—

 
(3,675
)
 
(1,825
)
Corporate
—

 
—

 
—

 
$
(2,900
)
 
$
(14,497
)
 
$
(14,471
)
Revenues:
 
 
 
 
 
U.S.
$
751,099

 
$
837,509

 
$
803,853

Ireland
81,170

 
78,102

 
80,905

Chile
33,642

 
41,216

 
44,286

Spain
18,747

 
18,195

 
18,285

Israel
8,769

 
9,479

 
13,951

Mexico
8,032

 
5,598

 
4,605

Other
476


167

 
121

 
$
901,935

 
$
990,266

 
$
966,006


(In thousands)
December 31,
2019
 
December 31,
2018
Assets:
 
 
 
Pharmaceutical
$
1,174,639

 
$
1,236,499

Diagnostics
1,035,112

 
1,162,160

Corporate
99,521

 
52,413

 
$
2,309,272

 
$
2,451,072

Goodwill:
 
 
 
Pharmaceutical
$
237,131

 
$
247,407

Diagnostics
434,809

 
452,786

Corporate
—

 
—

 
$
671,940

 
$
700,193
Property, Plant and Equipment, Net by Jurisdiction
The following table reconciles our Property, plant and equipment, net between U.S. and foreign jurisdictions: 
(In thousands)
December 31, 2019
 
December 31, 2018
PP&E:
 
 
 
U.S.
$
62,158

 
$
76,907

Foreign
64,953

 
67,767

Total
$
127,111

 
$
144,674